Clinical Trial Update: Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial [Phase 2]

View source ↗

Summary

Phase 2 trial (IMPACT-ADT) evaluating time-restricted eating, a GLP-1 receptor agonist, and a heart-healthy diet to improve cardiometabolic health in prostate c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GLP-1 receptor agonist (class) (glucagon-like peptide-1 receptor agonist)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Prostate Carcinoma, Recurrent Prostate Carcinoma | Phase 2 | Status: RECRUITING